vTv Therapeutics Stock

vTv Therapeutics ROA 2024

vTv Therapeutics ROA

-1.84

Ticker

VTVT

ISIN

US9183851057

WKN

A14XHJ

In 2024, vTv Therapeutics's return on assets (ROA) was -1.84, a 218.85% increase from the -0.58 ROA in the previous year.

vTv Therapeutics Aktienanalyse

What does vTv Therapeutics do?

vTv Therapeutics Inc is an American company that was founded in 2015 and is headquartered in High Point, North Carolina. The company operates in the pharmaceutical industry and focuses on the development of drugs for the treatment of metabolic and neurological disorders. vTv Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding vTv Therapeutics's Return on Assets (ROA)

vTv Therapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing vTv Therapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider vTv Therapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in vTv Therapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about vTv Therapeutics stock

What is the Return on Assets (ROA) of vTv Therapeutics this year?

The Return on Assets (ROA) of vTv Therapeutics is -1.84 undefined this year.

What was the ROA of vTv Therapeutics compared to the previous year?

The ROA of vTv Therapeutics has increased by 218.85% compared to the previous year.

What consequences do high ROA have for investors of vTv Therapeutics?

A high ROA is advantageous for investors of vTv Therapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in vTv Therapeutics?

A low ROA can be unfavorable for investors of vTv Therapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of vTv Therapeutics affect the company?

An increase in ROA of vTv Therapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of vTv Therapeutics impact the company?

A reduction in the ROA of vTv Therapeutics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of vTv Therapeutics?

Some factors that can influence the ROA of vTv Therapeutics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of vTv Therapeutics important for investors?

The ROA of vTv Therapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can vTv Therapeutics take to improve ROA?

To improve ROA, vTv Therapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does vTv Therapeutics pay?

Over the past 12 months, vTv Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, vTv Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of vTv Therapeutics?

The current dividend yield of vTv Therapeutics is .

When does vTv Therapeutics pay dividends?

vTv Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of vTv Therapeutics?

vTv Therapeutics paid dividends every year for the past 0 years.

What is the dividend of vTv Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is vTv Therapeutics located?

vTv Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von vTv Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of vTv Therapeutics from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did vTv Therapeutics pay the last dividend?

The last dividend was paid out on 9/19/2024.

What was the dividend of vTv Therapeutics in the year 2023?

In the year 2023, vTv Therapeutics distributed 0 USD as dividends.

In which currency does vTv Therapeutics pay out the dividend?

The dividends of vTv Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von vTv Therapeutics

Our stock analysis for vTv Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of vTv Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.